Clearside Biomedical Inc. (CLSD)
Market Closed
12 Mar, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 41
0
0%
Pre Market
$
-0.16 -39.2683% 0. 25
2.15M Market Cap
- P/E Ratio
- Div Yield
2.05M Volume
-0.53 Eps
$ 0.41
Previous Close Want to track CLSD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Clearside Biomedical Inc. (CLSD) Statistics
Valuation metrics
Market Cap 2.15M
Enterprise value -4.21M
Trailing P/E (ttm) -0.2
Forward P/E -
PEG ratio -0.01
Price/Sales (ttm) 3.1
Price/Book (mrq) -0.04
Enterprise Value/Revenue -6.07
Enterprise Value/EBITDA 0.85
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.22K
Average volume (90 days) 19
Price summary
52-Week low 0.31
52-Week high 17.1
Beta -
50-Day moving average 0.25
200-Day moving average 0.28
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:15
Last split Date 15 Sep 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -15.1%
Operating margin -15.31%
Operational effectiveness
Return on assets -0.9%
Return on equity 0.2%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.13
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.3
Total debt (mrq) -
Total Debt/Equity (mrq) -0.01
Current ratio (mrq) 2.98%
Book value per share (mrq) -10.31
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
